期刊文献+

款冬酮抗过敏作用研究 被引量:10

Antiallergic effect of tussilagone from Tussilago farfara L.
原文传递
导出
摘要 目的:评价款冬酮的抗过敏作用。方法:通过CO2超临界流体萃取、硅胶柱层析等方法,从款冬花中分离制备款冬酮;采用透明质酸酶抑制实验、肥大细胞(mast cell,MC)脱颗粒实验、豚鼠离体回肠实验、小鼠被动皮肤过敏反应(PCA)实验及小鼠迟发型超敏反应(DTH)实验,观察款冬酮抗过敏的药理作用。结果:款冬酮能显著抑制透明质酸酶的活性,其高、中、低剂量组的抑制率分别为68.6%,45.3%,29.6%;款冬酮能显著抑制肥大细胞脱颗粒作用,其高、中、低剂量组的抑制率分别为100.0%,51.0%,0%;款冬酮能显著抑制组胺致豚鼠离体回肠收缩作用,其高、低剂量组抑制率分别为64.9%,44.1%;款冬酮高、低剂量对组胺致小鼠皮肤速发过敏反应的抑制率分别52.3%,41.6%;款冬酮高、低剂量对2,4-二硝基氯苯(DNCB)致小鼠耳肿胀抑制率分别为25.6%,6.2%。结论:款冬酮具有较强的抗过敏作用。 Objective: To determine the antiallergic effect of tussilagone from Tussilago farfara L. Methods: Tussilagone was separated from Tussilago farfara L. by CO2 supercritical fluid extraction and silica gel column chromatography. Antiallergic effect of tussilagone was evaluated by hyaluronidase inhibition test,mast cell degranulation test,experiment in isolated ileum from guinea pig,experimental passive cutaneous anaphylaxis in mice and delayed-type hypersensitivity in mice. Results: Tussilagone significantly inhibited the activity of hyaluronidase by29. 6%,45. 3% and 68. 6% at 0. 26,0. 77 and 2. 30 mmol·L-1,and mast cell degranulation by 0%,51. 0%and 100. 0% at 1. 92 × 10-5,3. 84 × 10-5and 7. 68 × 10-5mol·L-1,respectively. It inhibited histamine-induced contraction of guinea pig ileum in vitro by 44. 1% and 64. 9% at 1. 54 and 3. 07 mmol·L-1. Tussilagone( 10. 7and 21. 5 mmol·L-1) inhibited histamine-induced immediate allergic reactions in mouse skin by 52. 3% and41. 6%,and DNCB-induced ear edema by 6. 2% and 25. 6% in mice. Conclusion: Tussilagone has a strong antiallergic effect.
出处 《中国新药杂志》 CAS CSCD 北大核心 2015年第13期1517-1522,共6页 Chinese Journal of New Drugs
基金 浙江省自然科学基金(LY15H280002)
关键词 款冬花 款冬酮 透明质酸 肥大细胞 离体回肠 被动皮肤过敏反应 迟发型超敏反应 Tussilago farara L. tussilagone hyaluronidase mast cell isolated ileum passive cutaneous anaphylaxis delayed-type hypersensit-ivity
  • 相关文献

参考文献23

  • 1ALVES CF, ANGELI GN, FACCIOLI LH, et al. The effects of proresolution of ellagic acid in an experimental model of allergic airway inflammation [ J ]. Mediators lnflamm, 2013, 2013 : 863198. 被引量:1
  • 2WARNER JO, KALINER MA, CRISCI CD, et al. Allergy practice worldwide: a report by the world allergy organization specialty and training council [ J ]. Int Allergy lmmunol, 2006,139 ( 2 ) : 166 - 174. 被引量:1
  • 3FORTUNATO LR, ALVES CF, TEIXEIRA MM, et al. Quercetin : a lavonoid with the potential to treat asthma [ J ]. Braz J Pharm Sei,2012,48(4) :589-599. 被引量:1
  • 4NAVE R,MUELLER H. From inhaler to lung: clinical implica- tions of the formulations of cielesonide and other inhaled cortico- steroids [ J ]. Int J Gen Med,2013,6 : 99 - 107. 被引量:1
  • 5NAMBA T. The encyclopedia of Wakan-Yaku Vol. Ⅱ[ M ]. Toky- o : Hoikusha publishing, 1980 : 525. 被引量:1
  • 6CHO JS,KIM HM, RYU JH,et al. Neuroprotective and antioxi- dant effects of the ethyl acetate fraction prepared from Tussilago farfara L[ J]. Biol Pharm Bull ,2005,28 ( 3 ) :455 - 460. 被引量:1
  • 7KOKOSKA L, POLESNY Z, RADA V,et al. Screening of some siberian medicinal plants for antimicrobial activity [ J]. J Ethno- pharmacol,2002,82 ( 1 ) :51 - 53. 被引量:1
  • 8LI H, LEE H J, AHN YH, et al. Tussilagone suppresses colon cancer cell proliferation by promoting the degradation of 13-catenin [J].2014,443(1) :132 - 137. 被引量:1
  • 9HWANGBO C, LEE HS, PARK J, et al. The anti-inflammatory effect of tussilagone, from Tussilagofarfara,is mediated by the in- duction of heine oxygenase-1 in murine macrophage[ J]. Int im- munopharmacol,2009,9 ( 13 - 14) : 1578 - 1584. 被引量:1
  • 10MASAO K, NORIKO S. Studies on the constituents of Tussilago farfara L. Ⅱ. Structure of new sesquiterpenoids isolated from the flower buds[ J ]. Chem Pharm Bull, 1992,40:2753 - 2755. 被引量:1

同被引文献98

引证文献10

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部